Global Mumps Drug Market Insights, Forecast to 2029

The global Mumps Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Mumps Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Mumps Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Mumps Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Mumps Drug include Beijing Minhai Biotechnology Co., Ltd, Beijing Tiantan Biological Products Co., Ltd., China National Pharmaceutical Group Corporation, GlaxoSmithKline Plc, Organic Vaccines, Prometheon Pharma, LLC, Sinovac Biotech Ltd. and Zydus Cadila Healthcare Limited, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Mumps Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Mumps Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Mumps Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mumps Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Mumps Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Mumps Drug sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Beijing Minhai Biotechnology Co., Ltd, Beijing Tiantan Biological Products Co., Ltd., China National Pharmaceutical Group Corporation, GlaxoSmithKline Plc, Organic Vaccines, Prometheon Pharma, LLC, Sinovac Biotech Ltd. and Zydus Cadila Healthcare Limited, etc.

1.1 Mumps Drug Product Introduction

1.2 Market by Type

1.2.1 Global Mumps Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 RIT 4385

1.2.3 Schwarz

1.2.4 Wistar RA 27/3

1.2.5 Others

1.3 Market by Application

1.3.1 Global Mumps Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Mumps Drug Sales Estimates and Forecasts 2018-2029

2.2 Global Mumps Drug Revenue by Region

2.2.1 Global Mumps Drug Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Mumps Drug Revenue by Region (2018-2023)

2.2.3 Global Mumps Drug Revenue by Region (2024-2029)

2.2.4 Global Mumps Drug Revenue Market Share by Region (2018-2029)

2.3 Global Mumps Drug Sales Estimates and Forecasts 2018-2029

2.4 Global Mumps Drug Sales by Region

2.4.1 Global Mumps Drug Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Mumps Drug Sales by Region (2018-2023)

2.4.3 Global Mumps Drug Sales by Region (2024-2029)

2.4.4 Global Mumps Drug Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3.1 Global Mumps Drug Sales by Manufacturers

3.1.1 Global Mumps Drug Sales by Manufacturers (2018-2023)

3.1.2 Global Mumps Drug Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mumps Drug in 2022

3.2 Global Mumps Drug Revenue by Manufacturers

3.2.1 Global Mumps Drug Revenue by Manufacturers (2018-2023)

3.2.2 Global Mumps Drug Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Mumps Drug Revenue in 2022

3.3 Global Key Players of Mumps Drug, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Mumps Drug Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Mumps Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Mumps Drug, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Mumps Drug, Product Offered and Application

3.8 Global Key Manufacturers of Mumps Drug, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4.1 Global Mumps Drug Sales by Type

4.1.1 Global Mumps Drug Historical Sales by Type (2018-2023)

4.1.2 Global Mumps Drug Forecasted Sales by Type (2024-2029)

4.1.3 Global Mumps Drug Sales Market Share by Type (2018-2029)

4.2 Global Mumps Drug Revenue by Type

4.2.1 Global Mumps Drug Historical Revenue by Type (2018-2023)

4.2.2 Global Mumps Drug Forecasted Revenue by Type (2024-2029)

4.2.3 Global Mumps Drug Revenue Market Share by Type (2018-2029)

4.3 Global Mumps Drug Price by Type

4.3.1 Global Mumps Drug Price by Type (2018-2023)

4.3.2 Global Mumps Drug Price Forecast by Type (2024-2029)

5.1 Global Mumps Drug Sales by Application

5.1.1 Global Mumps Drug Historical Sales by Application (2018-2023)

5.1.2 Global Mumps Drug Forecasted Sales by Application (2024-2029)

5.1.3 Global Mumps Drug Sales Market Share by Application (2018-2029)

5.2 Global Mumps Drug Revenue by Application

5.2.1 Global Mumps Drug Historical Revenue by Application (2018-2023)

5.2.2 Global Mumps Drug Forecasted Revenue by Application (2024-2029)

5.2.3 Global Mumps Drug Revenue Market Share by Application (2018-2029)

5.3 Global Mumps Drug Price by Application

5.3.1 Global Mumps Drug Price by Application (2018-2023)

5.3.2 Global Mumps Drug Price Forecast by Application (2024-2029)

6.1 US & Canada Mumps Drug Market Size by Type

6.1.1 US & Canada Mumps Drug Sales by Type (2018-2029)

6.1.2 US & Canada Mumps Drug Revenue by Type (2018-2029)

6.2 US & Canada Mumps Drug Market Size by Application

6.2.1 US & Canada Mumps Drug Sales by Application (2018-2029)

6.2.2 US & Canada Mumps Drug Revenue by Application (2018-2029)

6.3 US & Canada Mumps Drug Market Size by Country

6.3.1 US & Canada Mumps Drug Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Mumps Drug Sales by Country (2018-2029)

6.3.3 US & Canada Mumps Drug Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7.1 Europe Mumps Drug Market Size by Type

7.1.1 Europe Mumps Drug Sales by Type (2018-2029)

7.1.2 Europe Mumps Drug Revenue by Type (2018-2029)

7.2 Europe Mumps Drug Market Size by Application

7.2.1 Europe Mumps Drug Sales by Application (2018-2029)

7.2.2 Europe Mumps Drug Revenue by Application (2018-2029)

7.3 Europe Mumps Drug Market Size by Country

7.3.1 Europe Mumps Drug Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Mumps Drug Sales by Country (2018-2029)

7.3.3 Europe Mumps Drug Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8.1 China Mumps Drug Market Size

8.1.1 China Mumps Drug Sales (2018-2029)

8.1.2 China Mumps Drug Revenue (2018-2029)

8.2 China Mumps Drug Market Size by Application

8.2.1 China Mumps Drug Sales by Application (2018-2029)

8.2.2 China Mumps Drug Revenue by Application (2018-2029)

9.1 Asia Mumps Drug Market Size by Type

9.1.1 Asia Mumps Drug Sales by Type (2018-2029)

9.1.2 Asia Mumps Drug Revenue by Type (2018-2029)

9.2 Asia Mumps Drug Market Size by Application

9.2.1 Asia Mumps Drug Sales by Application (2018-2029)

9.2.2 Asia Mumps Drug Revenue by Application (2018-2029)

9.3 Asia Mumps Drug Sales by Region

9.3.1 Asia Mumps Drug Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Mumps Drug Revenue by Region (2018-2029)

9.3.3 Asia Mumps Drug Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10.1 Middle East, Africa and Latin America Mumps Drug Market Size by Type

10.1.1 Middle East, Africa and Latin America Mumps Drug Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Mumps Drug Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Mumps Drug Market Size by Application

10.2.1 Middle East, Africa and Latin America Mumps Drug Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Mumps Drug Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Mumps Drug Sales by Country

10.3.1 Middle East, Africa and Latin America Mumps Drug Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Mumps Drug Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Mumps Drug Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11.1 Beijing Minhai Biotechnology Co., Ltd

11.1.1 Beijing Minhai Biotechnology Co., Ltd Company Information

11.1.2 Beijing Minhai Biotechnology Co., Ltd Overview

11.1.3 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments

11.2 Beijing Tiantan Biological Products Co., Ltd.

11.2.1 Beijing Tiantan Biological Products Co., Ltd. Company Information

11.2.2 Beijing Tiantan Biological Products Co., Ltd. Overview

11.2.3 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments

11.3 China National Pharmaceutical Group Corporation

11.3.1 China National Pharmaceutical Group Corporation Company Information

11.3.2 China National Pharmaceutical Group Corporation Overview

11.3.3 China National Pharmaceutical Group Corporation Mumps Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 China National Pharmaceutical Group Corporation Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 China National Pharmaceutical Group Corporation Recent Developments

11.4 GlaxoSmithKline Plc

11.4.1 GlaxoSmithKline Plc Company Information

11.4.2 GlaxoSmithKline Plc Overview

11.4.3 GlaxoSmithKline Plc Mumps Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 GlaxoSmithKline Plc Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 GlaxoSmithKline Plc Recent Developments

11.5 Organic Vaccines

11.5.1 Organic Vaccines Company Information

11.5.2 Organic Vaccines Overview

11.5.3 Organic Vaccines Mumps Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Organic Vaccines Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Organic Vaccines Recent Developments

11.6 Prometheon Pharma, LLC

11.6.1 Prometheon Pharma, LLC Company Information

11.6.2 Prometheon Pharma, LLC Overview

11.6.3 Prometheon Pharma, LLC Mumps Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 Prometheon Pharma, LLC Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Prometheon Pharma, LLC Recent Developments

11.7 Sinovac Biotech Ltd.

11.7.1 Sinovac Biotech Ltd. Company Information

11.7.2 Sinovac Biotech Ltd. Overview

11.7.3 Sinovac Biotech Ltd. Mumps Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.7.4 Sinovac Biotech Ltd. Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Sinovac Biotech Ltd. Recent Developments

11.8 Zydus Cadila Healthcare Limited

11.8.1 Zydus Cadila Healthcare Limited Company Information

11.8.2 Zydus Cadila Healthcare Limited Overview

11.8.3 Zydus Cadila Healthcare Limited Mumps Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.8.4 Zydus Cadila Healthcare Limited Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Zydus Cadila Healthcare Limited Recent Developments

12.1 Mumps Drug Industry Chain Analysis

12.2 Mumps Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Mumps Drug Production Mode & Process

12.4 Mumps Drug Sales and Marketing

12.4.1 Mumps Drug Sales Channels

12.4.2 Mumps Drug Distributors

12.5 Mumps Drug Customers

13.1 Mumps Drug Industry Trends

13.2 Mumps Drug Market Drivers

13.3 Mumps Drug Market Challenges

13.4 Mumps Drug Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Mumps Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Table 2. Major Manufacturers of RIT 4385

    Table 3. Major Manufacturers of Schwarz

    Table 4. Major Manufacturers of Wistar RA 27/3

    Table 5. Major Manufacturers of Others

    Table 6. Global Mumps Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Table 7. Global Mumps Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 8. Global Mumps Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 9. Global Mumps Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 10. Global Mumps Drug Revenue Market Share by Region (2018-2023)

    Table 11. Global Mumps Drug Revenue Market Share by Region (2024-2029)

    Table 12. Global Mumps Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 13. Global Mumps Drug Sales by Region (2018-2023) & (K Pcs)

    Table 14. Global Mumps Drug Sales by Region (2024-2029) & (K Pcs)

    Table 15. Global Mumps Drug Sales Market Share by Region (2018-2023)

    Table 16. Global Mumps Drug Sales Market Share by Region (2024-2029)

    Table 17. Global Mumps Drug Sales by Manufacturers (2018-2023) & (K Pcs)

    Table 18. Global Mumps Drug Sales Share by Manufacturers (2018-2023)

    Table 19. Global Mumps Drug Revenue by Manufacturers (2018-2023) & (US$ Million)

    Table 20. Global Mumps Drug Revenue Share by Manufacturers (2018-2023)

    Table 21. Global Key Players of Mumps Drug, Industry Ranking, 2021 VS 2022 VS 2023

    Table 22. Mumps Drug Price by Manufacturers 2018-2023 (USD/Pcs)

    Table 23. Global Mumps Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 24. Global Mumps Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mumps Drug as of 2022)

    Table 25. Global Key Manufacturers of Mumps Drug, Manufacturing Base Distribution and Headquarters

    Table 26. Global Key Manufacturers of Mumps Drug, Product Offered and Application

    Table 27. Global Key Manufacturers of Mumps Drug, Date of Enter into This Industry

    Table 28. Mergers & Acquisitions, Expansion Plans

    Table 29. Global Mumps Drug Sales by Type (2018-2023) & (K Pcs)

    Table 30. Global Mumps Drug Sales by Type (2024-2029) & (K Pcs)

    Table 31. Global Mumps Drug Sales Share by Type (2018-2023)

    Table 32. Global Mumps Drug Sales Share by Type (2024-2029)

    Table 33. Global Mumps Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 34. Global Mumps Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 35. Global Mumps Drug Revenue Share by Type (2018-2023)

    Table 36. Global Mumps Drug Revenue Share by Type (2024-2029)

    Table 37. Mumps Drug Price by Type (2018-2023) & (USD/Pcs)

    Table 38. Global Mumps Drug Price Forecast by Type (2024-2029) & (USD/Pcs)

    Table 39. Global Mumps Drug Sales by Application (2018-2023) & (K Pcs)

    Table 40. Global Mumps Drug Sales by Application (2024-2029) & (K Pcs)

    Table 41. Global Mumps Drug Sales Share by Application (2018-2023)

    Table 42. Global Mumps Drug Sales Share by Application (2024-2029)

    Table 43. Global Mumps Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 44. Global Mumps Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 45. Global Mumps Drug Revenue Share by Application (2018-2023)

    Table 46. Global Mumps Drug Revenue Share by Application (2024-2029)

    Table 47. Mumps Drug Price by Application (2018-2023) & (USD/Pcs)

    Table 48. Global Mumps Drug Price Forecast by Application (2024-2029) & (USD/Pcs)

    Table 49. US & Canada Mumps Drug Sales by Type (2018-2023) & (K Pcs)

    Table 50. US & Canada Mumps Drug Sales by Type (2024-2029) & (K Pcs)

    Table 51. US & Canada Mumps Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 52. US & Canada Mumps Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 53. US & Canada Mumps Drug Sales by Application (2018-2023) & (K Pcs)

    Table 54. US & Canada Mumps Drug Sales by Application (2024-2029) & (K Pcs)

    Table 55. US & Canada Mumps Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 56. US & Canada Mumps Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 57. US & Canada Mumps Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 58. US & Canada Mumps Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 59. US & Canada Mumps Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 60. US & Canada Mumps Drug Sales by Country (2018-2023) & (K Pcs)

    Table 61. US & Canada Mumps Drug Sales by Country (2024-2029) & (K Pcs)

    Table 62. Europe Mumps Drug Sales by Type (2018-2023) & (K Pcs)

    Table 63. Europe Mumps Drug Sales by Type (2024-2029) & (K Pcs)

    Table 64. Europe Mumps Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 65. Europe Mumps Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 66. Europe Mumps Drug Sales by Application (2018-2023) & (K Pcs)

    Table 67. Europe Mumps Drug Sales by Application (2024-2029) & (K Pcs)

    Table 68. Europe Mumps Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 69. Europe Mumps Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 70. Europe Mumps Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 71. Europe Mumps Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 72. Europe Mumps Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 73. Europe Mumps Drug Sales by Country (2018-2023) & (K Pcs)

    Table 74. Europe Mumps Drug Sales by Country (2024-2029) & (K Pcs)

    Table 75. China Mumps Drug Sales by Type (2018-2023) & (K Pcs)

    Table 76. China Mumps Drug Sales by Type (2024-2029) & (K Pcs)

    Table 77. China Mumps Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 78. China Mumps Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 79. China Mumps Drug Sales by Application (2018-2023) & (K Pcs)

    Table 80. China Mumps Drug Sales by Application (2024-2029) & (K Pcs)

    Table 81. China Mumps Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 82. China Mumps Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 83. Asia Mumps Drug Sales by Type (2018-2023) & (K Pcs)

    Table 84. Asia Mumps Drug Sales by Type (2024-2029) & (K Pcs)

    Table 85. Asia Mumps Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 86. Asia Mumps Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 87. Asia Mumps Drug Sales by Application (2018-2023) & (K Pcs)

    Table 88. Asia Mumps Drug Sales by Application (2024-2029) & (K Pcs)

    Table 89. Asia Mumps Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 90. Asia Mumps Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 91. Asia Mumps Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 92. Asia Mumps Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 93. Asia Mumps Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 94. Asia Mumps Drug Sales by Region (2018-2023) & (K Pcs)

    Table 95. Asia Mumps Drug Sales by Region (2024-2029) & (K Pcs)

    Table 96. Middle East, Africa and Latin America Mumps Drug Sales by Type (2018-2023) & (K Pcs)

    Table 97. Middle East, Africa and Latin America Mumps Drug Sales by Type (2024-2029) & (K Pcs)

    Table 98. Middle East, Africa and Latin America Mumps Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 99. Middle East, Africa and Latin America Mumps Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 100. Middle East, Africa and Latin America Mumps Drug Sales by Application (2018-2023) & (K Pcs)

    Table 101. Middle East, Africa and Latin America Mumps Drug Sales by Application (2024-2029) & (K Pcs)

    Table 102. Middle East, Africa and Latin America Mumps Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 103. Middle East, Africa and Latin America Mumps Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 104. Middle East, Africa and Latin America Mumps Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 105. Middle East, Africa and Latin America Mumps Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 106. Middle East, Africa and Latin America Mumps Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 107. Middle East, Africa and Latin America Mumps Drug Sales by Country (2018-2023) & (K Pcs)

    Table 108. Middle East, Africa and Latin America Mumps Drug Sales by Country (2024-2029) & (K Pcs)

    Table 109. Beijing Minhai Biotechnology Co., Ltd Company Information

    Table 110. Beijing Minhai Biotechnology Co., Ltd Description and Major Businesses

    Table 111. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 112. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 113. Beijing Minhai Biotechnology Co., Ltd Recent Developments

    Table 114. Beijing Tiantan Biological Products Co., Ltd. Company Information

    Table 115. Beijing Tiantan Biological Products Co., Ltd. Description and Major Businesses

    Table 116. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 117. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 118. Beijing Tiantan Biological Products Co., Ltd. Recent Developments

    Table 119. China National Pharmaceutical Group Corporation Company Information

    Table 120. China National Pharmaceutical Group Corporation Description and Major Businesses

    Table 121. China National Pharmaceutical Group Corporation Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 122. China National Pharmaceutical Group Corporation Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 123. China National Pharmaceutical Group Corporation Recent Developments

    Table 124. GlaxoSmithKline Plc Company Information

    Table 125. GlaxoSmithKline Plc Description and Major Businesses

    Table 126. GlaxoSmithKline Plc Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 127. GlaxoSmithKline Plc Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 128. GlaxoSmithKline Plc Recent Developments

    Table 129. Organic Vaccines Company Information

    Table 130. Organic Vaccines Description and Major Businesses

    Table 131. Organic Vaccines Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 132. Organic Vaccines Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 133. Organic Vaccines Recent Developments

    Table 134. Prometheon Pharma, LLC Company Information

    Table 135. Prometheon Pharma, LLC Description and Major Businesses

    Table 136. Prometheon Pharma, LLC Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 137. Prometheon Pharma, LLC Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 138. Prometheon Pharma, LLC Recent Developments

    Table 139. Sinovac Biotech Ltd. Company Information

    Table 140. Sinovac Biotech Ltd. Description and Major Businesses

    Table 141. Sinovac Biotech Ltd. Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 142. Sinovac Biotech Ltd. Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 143. Sinovac Biotech Ltd. Recent Developments

    Table 144. Zydus Cadila Healthcare Limited Company Information

    Table 145. Zydus Cadila Healthcare Limited Description and Major Businesses

    Table 146. Zydus Cadila Healthcare Limited Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 147. Zydus Cadila Healthcare Limited Mumps Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 148. Zydus Cadila Healthcare Limited Recent Developments

    Table 149. Key Raw Materials Lists

    Table 150. Raw Materials Key Suppliers Lists

    Table 151. Mumps Drug Distributors List

    Table 152. Mumps Drug Customers List

    Table 153. Mumps Drug Market Trends

    Table 154. Mumps Drug Market Drivers

    Table 155. Mumps Drug Market Challenges

    Table 156. Mumps Drug Market Restraints

    Table 157. Research Programs/Design for This Report

    Table 158. Key Data Information from Secondary Sources

    Table 159. Key Data Information from Primary Sources

List of Figures

    Figure 1. Mumps Drug Product Picture

    Figure 2. Global Mumps Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 3. Global Mumps Drug Market Share by Type in 2022 & 2029

    Figure 4. RIT 4385 Product Picture

    Figure 5. Schwarz Product Picture

    Figure 6. Wistar RA 27/3 Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global Mumps Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 9. Global Mumps Drug Market Share by Application in 2022 & 2029

    Figure 10. Hospital

    Figure 11. Clinic

    Figure 12. Others

    Figure 13. Mumps Drug Report Years Considered

    Figure 14. Global Mumps Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Mumps Drug Revenue 2018-2029 (US$ Million)

    Figure 16. Global Mumps Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029

    Figure 17. Global Mumps Drug Revenue Market Share by Region (2018-2029)

    Figure 18. Global Mumps Drug Sales 2018-2029 ((K Pcs)

    Figure 19. Global Mumps Drug Sales Market Share by Region (2018-2029)

    Figure 20. US & Canada Mumps Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 21. US & Canada Mumps Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 22. Europe Mumps Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 23. Europe Mumps Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 24. China Mumps Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 25. China Mumps Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 26. Asia (excluding China) Mumps Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 27. Asia (excluding China) Mumps Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 28. Middle East, Africa and Latin America Mumps Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 29. Middle East, Africa and Latin America Mumps Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 30. The Mumps Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

    Figure 31. The Top 5 and 10 Largest Manufacturers of Mumps Drug in the World: Market Share by Mumps Drug Revenue in 2022

    Figure 32. Global Mumps Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

    Figure 33. Global Mumps Drug Sales Market Share by Type (2018-2029)

    Figure 34. Global Mumps Drug Revenue Market Share by Type (2018-2029)

    Figure 35. Global Mumps Drug Sales Market Share by Application (2018-2029)

    Figure 36. Global Mumps Drug Revenue Market Share by Application (2018-2029)

    Figure 37. US & Canada Mumps Drug Sales Market Share by Type (2018-2029)

    Figure 38. US & Canada Mumps Drug Revenue Market Share by Type (2018-2029)

    Figure 39. US & Canada Mumps Drug Sales Market Share by Application (2018-2029)

    Figure 40. US & Canada Mumps Drug Revenue Market Share by Application (2018-2029)

    Figure 41. US & Canada Mumps Drug Revenue Share by Country (2018-2029)

    Figure 42. US & Canada Mumps Drug Sales Share by Country (2018-2029)

    Figure 43. U.S. Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 44. Canada Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 45. Europe Mumps Drug Sales Market Share by Type (2018-2029)

    Figure 46. Europe Mumps Drug Revenue Market Share by Type (2018-2029)

    Figure 47. Europe Mumps Drug Sales Market Share by Application (2018-2029)

    Figure 48. Europe Mumps Drug Revenue Market Share by Application (2018-2029)

    Figure 49. Europe Mumps Drug Revenue Share by Country (2018-2029)

    Figure 50. Europe Mumps Drug Sales Share by Country (2018-2029)

    Figure 51. Germany Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 52. France Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 53. U.K. Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 54. Italy Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 55. Russia Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 56. China Mumps Drug Sales Market Share by Type (2018-2029)

    Figure 57. China Mumps Drug Revenue Market Share by Type (2018-2029)

    Figure 58. China Mumps Drug Sales Market Share by Application (2018-2029)

    Figure 59. China Mumps Drug Revenue Market Share by Application (2018-2029)

    Figure 60. Asia Mumps Drug Sales Market Share by Type (2018-2029)

    Figure 61. Asia Mumps Drug Revenue Market Share by Type (2018-2029)

    Figure 62. Asia Mumps Drug Sales Market Share by Application (2018-2029)

    Figure 63. Asia Mumps Drug Revenue Market Share by Application (2018-2029)

    Figure 64. Asia Mumps Drug Revenue Share by Region (2018-2029)

    Figure 65. Asia Mumps Drug Sales Share by Region (2018-2029)

    Figure 66. Japan Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 67. South Korea Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 68. China Taiwan Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 69. Southeast Asia Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 70. India Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 71. Middle East, Africa and Latin America Mumps Drug Sales Market Share by Type (2018-2029)

    Figure 72. Middle East, Africa and Latin America Mumps Drug Revenue Market Share by Type (2018-2029)

    Figure 73. Middle East, Africa and Latin America Mumps Drug Sales Market Share by Application (2018-2029)

    Figure 74. Middle East, Africa and Latin America Mumps Drug Revenue Market Share by Application (2018-2029)

    Figure 75. Middle East, Africa and Latin America Mumps Drug Revenue Share by Country (2018-2029)

    Figure 76. Middle East, Africa and Latin America Mumps Drug Sales Share by Country (2018-2029)

    Figure 77. Brazil Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 78. Mexico Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 79. Turkey Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 80. Israel Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 81. GCC Countries Mumps Drug Revenue (2018-2029) & (US$ Million)

    Figure 82. Mumps Drug Value Chain

    Figure 83. Mumps Drug Production Process

    Figure 84. Channels of Distribution

    Figure 85. Distributors Profiles

    Figure 86. Bottom-up and Top-down Approaches for This Report

    Figure 87. Data Triangulation

    Figure 88. Key Executives Interviewed